To help private industry quickly produce and distribute tests that meet NIH standards, lawmakers gave another $1 billion to the Biomedical Advanced ...
News
- US faces 'truly daunting' challenges on needed COVID tests
- 22nd Century: 1Q Earnings Snapshot
The plant biotechnology company posted revenue of $7.1 million in the period. The company's shares closed at 79 cents. A year ago, they were ...
- Momenta: 1Q Earnings Snapshot
The biotechnology company posted revenue of $8.9 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected ...
- Agenus: 1Q Earnings Snapshot
The biotechnology company posted revenue of $15.1 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected ...
- Bio-Rad: 1Q Earnings Snapshot
The maker of instruments used in biomedical research posted revenue of $571.6 million in the period. Bio-Rad shares have risen 21% since the ...